RhAPPcast: Lost Time: The Impact of Delaying Optimal Therapy in RA & SpA Patients Without Disease Control

In this RhAPPcast episode, host Amanda Mixon, PA-C, welcomes Jeannette Hart, PA-C, a seasoned rheumatology provider and RhAPP faculty member, to explore the consequences of treatment delays and strategies for ensuring timely intervention. Delaying optimal treatment for rheumatoid arthritis (RA) and spondyloarthropathies (SpA) can lead to irreversible joint damage, disease progression, and diminished quality of life.This discussion covers the common barriers to early treatment, including limited specialist access, patient hesitancy, and insurance hurdles, as well as the long-term risks of delayed therapy. Identifying high-risk patients through clinical assessments, disease activity scores, and patient-reported symptoms is essential for early intervention. Additionally, innovative practice efficiency solutions, such as virtual visits, team-based workflows, and improved scheduling strategies, can help streamline care and prevent unnecessary delays.One critical takeaway is the danger of complacency in disease management. Even when a patient shows some improvement, it may not be enough to prevent long-term damage. Advanced practice providers (APPs) play a pivotal role in advocating for treatment escalation and ensuring that patients receive the most effective therapies as early as possible.For more expert insights into rheumatology care, visit RhAPP.org or explore the RhAPP ACE App.